Sherry Cao

Sherry Cao has held various positions in the scientific and computational fields since 1999. Sherry began their career as a Post Doctoral at Harvard University in 1999, followed by a Director role at Genzyme Sanofi in 2000. In 2016, they became Group Head, Immunology Systems Computational Biology and Group Head, Scientific IT Informatics at AbbVie. Most recently in 2021, they were appointed VP of Computational Science at Affinia Therapeutics.

Sherry Cao obtained a Ph.D. in Biochemistry from Yale University, an MBA from Babson F.W. Olin Graduate School of Business, and attended Fudan University.